Larvol Delta - OBI-Pharma-announces-US-FDA-clearance-of-IND-application-for-a-phase-12-study-of-its-antibodydrug-conjugate-ADC-targeted-cancer-therapy-OBI999

OBI-999 - OBI Pharma

https://www.prnewswire.com/news-releases/obi-pharma-announces-us-fda-clearance-of-ind-application-for-a-phase-12-study-of-its-antibody-drug-conjugate-adc-targeted-cancer-therapy-obi-999-300910121.html

Sep 3, 2019

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next